About
René R. Kuijten is a Partner and Head of EQT Life Sciences. He was a responsible advisor for Neuravi, a company that developed an innovative stroke treatment and was acquired by Johnson & Johnson in 2017.
Sign up to see Dr René Kuijten's full profile
Access investment thesis, focus areas, bio, and contact details for Dr René Kuijten and 22,000+ other VC professionals.
EQT Life Sciences
Amsterdam, NL